Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

488 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditional PTEN-deficient mice as a prostate cancer chemoprevention model.
Koike H, Nozawa M, De Velasco MA, Kura Y, Ando N, Fukushima E, Yamamoto Y, Hatanaka Y, Yoshikawa K, Nishio K, Uemura H. Koike H, et al. Among authors: nozawa m. Asian Pac J Cancer Prev. 2015;16(5):1827-31. doi: 10.7314/apjcp.2015.16.5.1827. Asian Pac J Cancer Prev. 2015. PMID: 25773832 Free article.
Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.
Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H. Minami T, et al. Among authors: nozawa m. Int Immunopharmacol. 2014 May;20(1):59-65. doi: 10.1016/j.intimp.2014.02.018. Epub 2014 Feb 26. Int Immunopharmacol. 2014. PMID: 24583149
New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles.
Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco MA, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H. Minami T, et al. Among authors: nozawa m. Int Immunopharmacol. 2015 May;26(1):133-8. doi: 10.1016/j.intimp.2015.03.023. Epub 2015 Mar 27. Int Immunopharmacol. 2015. PMID: 25819666
A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate Cancer.
Yoshimura K, Minami T, Nozawa M, Kimura T, Egawa S, Fujimoto H, Yamada A, Itoh K, Uemura H. Yoshimura K, et al. Among authors: nozawa m. Eur Urol. 2016 Jul;70(1):35-41. doi: 10.1016/j.eururo.2015.12.050. Epub 2016 Jan 15. Eur Urol. 2016. PMID: 26782346 Free article. Clinical Trial.
488 results